BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Leber B, Mayrhauser U, Rybczynski M, Stadlbauer V. Innate immune dysfunction in acute and chronic liver disease. Wien Klin Wochenschr. 2009;121:732-744. [PMID: 20047110 DOI: 10.1007/s00508-009-1288-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 32] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Jalan R, Stadlbauer V, Sen S, Cheshire L, Chang YM, Mookerjee RP. Role of predisposition, injury, response and organ failure in the prognosis of patients with acute-on-chronic liver failure: a prospective cohort study. Crit Care. 2012;16:R227. [PMID: 23186071 DOI: 10.1186/cc11882] [Cited by in Crossref: 74] [Cited by in F6Publishing: 68] [Article Influence: 7.4] [Reference Citation Analysis]
2 Foldi I, Tornai T, Tornai D, Sipeki N, Vitalis Z, Tornai I, Dinya T, Antal-Szalmas P, Papp M. Lectin-complement pathway molecules are decreased in patients with cirrhosis and constitute the risk of bacterial infections. Liver Int 2017;37:1023-31. [PMID: 28109038 DOI: 10.1111/liv.13368] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
3 Dayem Ullah AZM, Sivapalan L, Kocher HM, Chelala C. COVID-19 in patients with hepatobiliary and pancreatic diseases: a single-centre cross-sectional study in East London. BMJ Open 2021;11:e045077. [PMID: 33875444 DOI: 10.1136/bmjopen-2020-045077] [Reference Citation Analysis]
4 Sipeki N, Antal-Szalmas P, Lakatos PL, Papp M. Immune dysfunction in cirrhosis. World J Gastroenterol 2014; 20(10): 2564-2577 [PMID: 24627592 DOI: 10.3748/wjg.v20.i10.2564] [Cited by in CrossRef: 97] [Cited by in F6Publishing: 78] [Article Influence: 12.1] [Reference Citation Analysis]
5 Stadlbauer V, Horvath A, Komarova I, Schmerboeck B, Feldbacher N, Wurm S, Klymiuk I, Durdevic M, Rainer F, Blesl A, Stryeck S, Madl T, Stiegler P, Leber B. A single alcohol binge impacts on neutrophil function without changes in gut barrier function and gut microbiome composition in healthy volunteers. PLoS One 2019;14:e0211703. [PMID: 30707717 DOI: 10.1371/journal.pone.0211703] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
6 Fuhrmann V, Jäger B, Zubkova A, Drolz A. Hypoxic hepatitis - epidemiology, pathophysiology and clinical management. Wien Klin Wochenschr. 2010;122:129-139. [PMID: 20361374 DOI: 10.1007/s00508-010-1357-6] [Cited by in Crossref: 66] [Cited by in F6Publishing: 53] [Article Influence: 5.5] [Reference Citation Analysis]
7 Laleman W, Verbeke L, Meersseman P, Wauters J, van Pelt J, Cassiman D, Wilmer A, Verslype C, Nevens F. Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions. Expert Rev Gastroenterol Hepatol. 2011;5:523-537; quiz 537. [PMID: 21780899 DOI: 10.1586/egh.11.47] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 6.0] [Reference Citation Analysis]
8 Tuchendler E, Tuchendler PK, Madej G. Immunodeficiency caused by cirrhosis. Clin Exp Hepatol 2018;4:158-64. [PMID: 30324140 DOI: 10.5114/ceh.2018.78119] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
9 Horvath A, Leber B, Lemesch S, Stadlbauer V. Hospital mortality of cirrhosis: better, but still room for improvement! Liver Int 2013;33:809-10. [DOI: 10.1111/liv.12166] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
10 Akbal E, Koçak E, Köklü S, Ergül B, Akyürek Ö, Yılmaz FM. Serum Toll-Like Receptor-2, Toll-Like Receptor-4 Levels in Patients with HBeAg-Negative Chronic Viral Hepatitis B. Viral Immunol 2017;30:278-82. [PMID: 28414577 DOI: 10.1089/vim.2016.0131] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
11 Lemesch S, Ribitsch W, Schilcher G, Spindelböck W, Hafner-Gießauf H, Marsche G, Pasterk L, Payerl D, Schmerböck B, Tawdrous M, Rosenkranz AR, Stiegler P, Kager G, Hallström S, Oettl K, Eberhard K, Horvath A, Leber B, Stadlbauer V. Mode of renal replacement therapy determines endotoxemia and neutrophil dysfunction in chronic kidney disease. Sci Rep 2016;6:34534. [PMID: 27698480 DOI: 10.1038/srep34534] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
12 Shi F, Zhang JY, Zeng Z, Tien P, Wang FS. Skewed ratios between CD3(+) T cells and monocytes are associated with poor prognosis in patients with HBV-related acute-on-chronic liver failure. Biochem Biophys Res Commun. 2010;402:30-36. [PMID: 20883666 DOI: 10.1016/j.bbrc.2010.09.096] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
13 Engelmann C, Becker C, Boldt A, Herta T, Boehlig A, Splith K, Schmelzle M, Mueller N, Krohn S, Tautenhahn HM, Bartels M, Sack U, Berg T. Ascites' neutrophil function is significantly impaired in patients with decompensated cirrhosis but can be restored by autologous plasma incubation. Sci Rep. 2016;6:37926. [PMID: 27917877 DOI: 10.1038/srep37926] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
14 Blackard JT, Welge JA, Taylor LE, Mayer KH, Klein RS, Celentano DD, Jamieson DJ, Gardner L, Sherman KE. HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in women. Clin Infect Dis. 2011;52:674-680. [PMID: 21248367 DOI: 10.1093/cid/ciq199] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 5.8] [Reference Citation Analysis]
15 Colonetti K, Roesch LF, Schwartz IVD. The microbiome and inborn errors of metabolism: Why we should look carefully at their interplay? Genet Mol Biol 2018;41:515-32. [PMID: 30235399 DOI: 10.1590/1678-4685-GMB-2017-0235] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
16 Oh TK, Jang ES, Song IA. Long-term mortality due to infection associated with elevated liver enzymes: a population-based cohort study. Sci Rep 2021;11:12490. [PMID: 34127778 DOI: 10.1038/s41598-021-92033-1] [Reference Citation Analysis]
17 [DOI: 10.1101/2020.09.07.20189621] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
18 Papp M, Sipeki N, Vitalis Z, Tornai T, Altorjay I, Tornai I, Udvardy M, Fechner K, Jacobsen S, Teegen B, Sumegi A, Veres G, Lakatos PL, Kappelmayer J, Antal-szalmas P. High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis. Journal of Hepatology 2013;59:457-66. [DOI: 10.1016/j.jhep.2013.04.018] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
19 Garg V, Garg H, Khan A, Trehanpati N, Kumar A, Sharma BC, Sakhuja P, Sarin SK. Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure. Gastroenterology 2012;142:505-512.e1. [PMID: 22119930 DOI: 10.1053/j.gastro.2011.11.027] [Cited by in Crossref: 219] [Cited by in F6Publishing: 209] [Article Influence: 19.9] [Reference Citation Analysis]
20 Hung TH, Hsieh MH, Lay CJ, Tsai CC, Tsai CC. Increased occurrence of native septic arthritis in adult cirrhotic patients: a population-based three-year follow-up study in Taiwan. Prz Gastroenterol 2014;9:342-7. [PMID: 25653729 DOI: 10.5114/pg.2014.47896] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Macpherson AJ, Heikenwalder M, Ganal-Vonarburg SC. The Liver at the Nexus of Host-Microbial Interactions. Cell Host Microbe 2016;20:561-71. [PMID: 27832587 DOI: 10.1016/j.chom.2016.10.016] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 10.0] [Reference Citation Analysis]
22 Amin N, Shah I, Bhatnagar S. Hemophagocytic Lymphohistiocytosis (HLH) in Children Presenting as Liver Disease. J Clin Exp Hepatol 2014;4:175-7. [PMID: 25755554 DOI: 10.1016/j.jceh.2013.06.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
23 Pastor-Clerigues A, Marti-Bonmati E, Milara J, Almudever P, Cortijo J. Anti-inflammatory and anti-fibrotic profile of fish oil emulsions used in parenteral nutrition-associated liver disease. PLoS One 2014;9:e115404. [PMID: 25502575 DOI: 10.1371/journal.pone.0115404] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
24 Verbeke L, Nevens F, Laleman W. Bench-to-beside review: acute-on-chronic liver failure - linking the gut, liver and systemic circulation. Crit Care 2011;15:233. [PMID: 22104633 DOI: 10.1186/cc10424] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
25 Hu T, Yao L, Hu A, Jiang S, Ying H, Deng Q, Hu Y, Zhou W, Xiong T. Nucleos(t)ide analogs improve long-term prognosis in patients with chronic hepatitis B-associated liver failure: Nucleos(t)ide analogs improve prognosis. Hepatol Res 2017;47:347-58. [DOI: 10.1111/hepr.12755] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
26 Horvath A, Leber B, Feldbacher N, Tripolt N, Rainer F, Blesl A, Trieb M, Marsche G, Sourij H, Stadlbauer V. Effects of a multispecies synbiotic on glucose metabolism, lipid marker, gut microbiome composition, gut permeability, and quality of life in diabesity: a randomized, double-blind, placebo-controlled pilot study. Eur J Nutr 2020;59:2969-83. [PMID: 31729622 DOI: 10.1007/s00394-019-02135-w] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
27 Wang Y, Yang YX. Advances in understanding the role of complement in the pathogenesis of fatty liver disease. Shijie Huaren Xiaohua Zazhi 2010; 18(15): 1577-1581 [DOI: 10.11569/wcjd.v18.i15.1577] [Reference Citation Analysis]
28 Spindelboeck W, Horvath A, Tawdrous M, Schmerböck B, Zettel G, Posch A, Streit A, Jurse P, Lemesch S, Horn M, Wuensch G, Stiegler P, Stauber RE, Leber B, Stadlbauer V. Triple Therapy with First Generation Protease Inhibitors for Hepatitis C Markedly Impairs Function of Neutrophil Granulocytes. PLoS One 2016;11:e0150299. [PMID: 26938078 DOI: 10.1371/journal.pone.0150299] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
29 Dong X, Gong Y, Zeng H, Hao Y, Wang X, Hou J, Wang J, Li J, Zhu Y, Liu H. Imbalance between circulating CD4+ regulatory T and conventional T lymphocytes in patients with HBV-related acute-on-chronic liver failure. Liver Int. 2013;33:1517-1526. [PMID: 23869954 DOI: 10.1111/liv.12248] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
30 Jäger B, Drolz A, Michl B, Schellongowski P, Bojic A, Nikfardjam M, Zauner C, Heinz G, Trauner M, Fuhrmann V. Jaundice increases the rate of complications and one-year mortality in patients with hypoxic hepatitis. Hepatology 2012;56:2297-304. [PMID: 22706920 DOI: 10.1002/hep.25896] [Cited by in Crossref: 56] [Cited by in F6Publishing: 46] [Article Influence: 5.6] [Reference Citation Analysis]
31 Al-Khafaji A, Huang DT. Critical care management of patients with end-stage liver disease. Crit Care Med 2011;39:1157-66. [PMID: 21336121 DOI: 10.1097/CCM.0b013e318211fdc4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
32 Mahendra M, Jayaraj BS, Limaye S, Chaya SK, Dhar R, Mahesh PA. Factors influencing severity of community-acquired pneumonia. Lung India 2018;35:284-9. [PMID: 29970765 DOI: 10.4103/lungindia.lungindia_334_17] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]